The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996

被引：56

作者：

OReilly, S

Rowinsky, EK

机构：

[1] JOHNS HOPKINS UNIV,CTR ONCOL,DIV MED ONCOL,BALTIMORE,MD 21287

[2] JOHNS HOPKINS UNIV,CTR ONCOL,DIV PHARMACOL & EXPT THERAPEUT,BALTIMORE,MD 21287

来源：

CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | 1996年 / 24卷 / 01期

关键词：

D O I：

10.1016/1040-8428(96)00211-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：47 / 70

页数：24

共 203 条

[1] PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS [J].

ABIGERGES, D ;

CHABOT, GG ;

ARMAND, JP ;

HERAIT, P ;

GOUYETTE, A ;

GANDIA, D .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :210-221

[2] IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA [J].

ABIGERGES, D ;

ARMAND, JP ;

CHABOT, GG ;

DACOSTA, L ;

FADEL, E ;

COTE, C ;

HERAIT, P ;

GANDIA, D .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :446-449

[3]

AKUTSU M, 1994, JPN J CANC CHEMOTHER, V21, P1607

[4]

ALLER P, 1992, CANCER RES, V52, P1245

[5] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J].

ANDOH, T ;

ISHII, K ;

SUZUKI, Y ;

IKEGAMI, Y ;

KUSUNOKI, Y ;

TAKEMOTO, Y ;

OKADA, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5565-5569

[6]

ANZAI H, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P431

[7] RELATIONSHIP BETWEEN DEVELOPMENT OF DIARRHEA AND THE CONCENTRATION OF SN-38, AN ACTIVE METABOLITE OF CPT-11, IN THE INTESTINE AND THE BLOOD-PLASMA OF ATHYMIC MICE FOLLOWING INTRAPERITONEAL ADMINISTRATION OF CPT-11 [J].

ARAKI, E ;

ISHIKAWA, M ;

IIGO, M ;

KOIDE, T ;

ITABASHI, M ;

HOSHI, A .

JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (06) :697-702

[8] CAMPTOTHECIN ANALOGS IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER [J].

ARDIZZONI, A .

LUNG CANCER, 1995, 12 :S177-S185

[9] CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER [J].

ARMAND, JP ;

DUCREUX, M ;

MAHJOUBI, M ;

ABIGERGES, D ;

BUGAT, R ;

CHABOT, G ;

HERAIT, P ;

DEFORNI, M ;

ROUGIER, P .

EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1283-1287

[10] APOPTOSIS AND ITS MODULATION IN HUMAN PROMYELOCYTIC HL-60 CELLS TREATED WITH DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS [J].

BERTRAND, R ;

SOLARY, E ;

JENKINS, J ;

POMMIER, Y .

EXPERIMENTAL CELL RESEARCH, 1993, 207 (02) :388-397

← 1 2 3 4 5 6 7 8 9 10 →